| View |
|
DR-XY46618 (FOR EXPORT ONLY)
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Sambactam
|
500mg/ 250mg
|
Powder for Injection (IM/IV)
|
Antibacterials (combination of penicillins, including beta-lactamase inhibitors)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
28 April 2024
|
20 June 2029
|
| View |
|
DR-XY46621
|
Pemetrexed (as disodium)
|
Podoxred
|
100mg
|
Lyophilized Powder For Injection (IV Infusion)
|
Antineoplastic (Antimetabolite)
|
Dr. Reddy's Laboratories Ltd.
|
India
|
Renewal
|
17 May 2024
|
27 June 2029
|
| View |
|
DR-XY46622
|
Pemetrexed (as disodium)
|
Podoxred
|
500mg
|
Lyophilized Powder For Injection (IV Infusion)
|
Antineoplastic (Antimetabolite)
|
Dr. Reddy's Laboratories Ltd.
|
India
|
Renewal
|
18 May 2024
|
27 June 2029
|
| View |
|
DR-XY46633
|
Peritoneal Dialysis Solution with 1.5% Dextrose
|
Europersol
|
Each 100mL contains 1.5 g Dextrose Monohydrate, 550mg Sodium Chloride, 392mg Sodium Lactate, Anhydrous (equivalent to 784mg Sodium Lactate Solution, 50%, 25.70 Calcium Chloride, Dihydrate, 15.2mg Magnesium Chloride, Hexahydrate & 30mg Sodium Metabisulfite)
|
Dialysis Solution (Intraperitoneal)
|
Peritoneal Dialytics
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Renewal
|
06 February 2024
|
01 July 2029
|
| View |
|
DR-XY46634
|
Fluorouracil
|
Fluoroxil
|
50mg/Ml
|
Solution for Injection (IV)
|
Antineoplastic (Antimetabolite)
|
Ildong Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
12 August 2024
|
19 August 2029
|
| View |
|
DR-XY46638
|
Entecavir (as monohydrate)
|
Unbranded
|
500 mcg
|
Film - Coated Tablet
|
Antiviral (Nucleoside and Nucleotide Reverse Transcriptase Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 March 2024
|
03 July 2029
|
| View |
|
DR-XY46640
|
Paracetamol + Phenylephrine
|
Colzap
|
500 mg / 10 mg
|
Tablet
|
Analgesic / Antipyretic / Nasal Decongestant
|
Saga Laboratories
|
India
|
Renewal
|
20 February 2024
|
09 July 2029
|
| View |
|
DR-XY46643
|
Iodine (as Iohexol)
|
Unihexol 350
|
350mg/mL
|
Solution For Iv Injection
|
Watersoluble, nephrotropic, low osmolar X-ray contrast media
|
Unique Pharmaceutical Laboratories
|
India
|
Renewal
|
23 June 2024
|
14 August 2029
|
| View |
|
DR-XY46653
|
Cefuroxime (as axetil)
|
Zegen
|
500mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Pt. Darya-Varia Laboratoria TBK
|
Indonesia
|
Renewal
|
21 April 2024
|
24 July 2029
|
| View |
|
DR-XY46655
|
Paclitaxel
|
Paclisun 300
|
300 mg/2.73 mL
|
Concentrate Solution for IV Infusion
(albumin-free Concentrate for Nanodispersion)
|
Antineoplastic
|
Sun Pharmaceutical Industries Ltd., India
|
India
|
Monitored Release (Reconstruction)
|
31 July 2024
|
09 November 2026
|
| View |
|
DR-XY46657
|
Zoledronic acid
|
Zoruxa
|
5 mg / 100 mL
|
Solution for IV Infusion
|
Biphosphonates
|
Gland Pharma Limited
|
India
|
Renewal
|
12 March 2024
|
05 August 2029
|
| View |
|
DR-XY46663
|
Ascorbic Acid
|
None
|
500 mg (equivalent to 562 mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
Vonwelt, Inc.
|
Philippines
|
Automatic Renewal (OTC)
|
07 May 2021
|
31 July 2026
|
| View |
|
DR-XY46664
|
Thiamine Hydrochloride (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Pascual Laboratories, Inc.
|
Philippines
|
Renewal
|
15 June 2024
|
31 July 2029
|
| View |
|
DR-XY46665
|
Ascorbic Acid + Zinc
|
Ascozin
|
500 mg (equivalent to 100 mg Ascorbic Acid and 450 mg Sodium Ascorbate) / 15 mg (equivalent to 18.67 mg Zinc Oxide)
|
Chewable Tablet
|
-
|
Kusum Healthcare Pvt. Ltd.
|
India
|
Automatic Renewal
|
22 June 2021
|
31 July 2026
|
| View |
|
DR-XY46671
|
Hyoscine-N-Butylbromide
|
Gastrohex
|
10 mg
|
Sugar-coated Tablet
|
Anticholinergic
|
Saga Laboratories
|
India
|
Renewal
|
23 June 2024
|
05 August 2029
|
| View |
|
DR-XY46677
|
Isoxsuprine hydrochloride
|
Duvadrine
|
5mg/Ml (10mg/2mL)
|
Solution for Injection (IV. Infusion/.IM)
|
-
|
Friends Pharma (Pvt) Ltd.
|
Pakistan
|
-
|
14 October 2019
|
14 October 2024
|
| View |
|
DR-XY46678
|
Sterile Water for Injection
|
Unbranded
|
None
|
Solution for injection
|
Parenteral Diluent
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Renewal
|
13 March 2024
|
15 August 2029
|
| View |
|
DR-XY46679
|
5% Dextrose in Water
|
Unbranded
|
5g/100mL
|
Solution for Infusion
|
Parenteral Diluent
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Renewal
|
19 May 2024
|
14 October 2029
|
| View |
|
DR-XY46680
|
Telmisartan
|
Micavid 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Jubilant Generics Limited
|
India
|
Renewal
|
17 April 2024
|
19 August 2029
|
| View |
|
DR-XY46681
|
Telmisartan
|
Micavid 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Jubilant Generics Limited
|
India
|
Renewal
|
07 April 2024
|
19 August 2029
|